Reported Reactions

Manufacturers

Device manufacturer, as written on reports

Tandem Diabetes Care: medical device reports filed with FDA

1,373,250 reports name it as the manufacturer of the device involved, 2013–2026.

1,373,250
reports naming it as manufacturer
5.3% of all MAUDE reports
244,646
reports, 12 months to August 2026
246,982 in the 12 months before
88%
classified as malfunction
62.3% across all reports
0%
classified as death, as reported
0.9% across all reports

1,373,250 medical device reports received by FDA give Tandem Diabetes Care as the manufacturer of the device involved, 5.3% of the MAUDE database, from May 2013 to August 2026. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.

244,646 reports arrived in the 12 months to August 2026, close to the 246,982 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (88%) and injury (11.9%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands named most often

BrandDevice typeReportsLatest 12 monthsClassified as death
t:slim X2 Insulin Pump with Control-IQ TechnologyAlternate controller enabled insulin infusion pump584,122129,1190%
t:slim X2 Insulin Pump with Interoperable Technology (with t:connect mobile app)Alternate controller enabled insulin infusion pump267,62911,5020%
t:slim X2 Insulin Pump with Basal-IQ TechnologyAutomated insulin dosing , threshold suspend142,6351,9160%
t:slim X2 Insulin Pump with Control-IQ+ TechnologyAlternate controller enabled insulin infusion pump65,29757,9360%
Tandem T Slim Insulin Delivery SystemPump, infusion, insulin52,25100.1%
t:slim X2 Insulin Pump with Interoperable TechnologyAlternate controller enabled insulin infusion pump37,1288650%
Tandem Mobi Insulin Pump with Control-IQ+ TechnologyAlternate controller enabled insulin infusion pump36,49931,6740%
T Slim G5 SystemPump, infusion, insulin, to be used with invasive glucose sensor36,25000%
t:slim G4 systemPump, infusion, insulin, to be used with invasive glucose sensor35,415200%
t:slim X2 Insulin PumpPump, infusion, insulin31,147860%
Tandem Mobi Insulin Pump with Interoperable TechnologyAlternate controller enabled insulin infusion pump27,9511,5950%
t:slim Insulin Delivery SystemPump, infusion, insulin19,276300.1%
Tandem Mobi Insulin Pump with Control-IQ TechnologyAlternate controller enabled insulin infusion pump15,1539,5530%
T Flex Insulin Delivery SystemPump, infusion, insulin11,22000.1%
T Slim X2 Basal-Iq Mmol/LAutomated insulin dosing , threshold suspend3,12000%
T Slim X2 Insulin Pump With Interoperable Technology With T Connect Mobile AAlternate controller enabled insulin infusion pump2,55500%
Tandem T Flex Insulin Delivery SystemPump, infusion, insulin52800.2%
T Slim X2 Basal Iq Mg/DlAutomated insulin dosing , threshold suspend47700%
T Slim X2 Insulin Pump With Interoperable Technology With T Connect Mobile ApAlternate controller enabled insulin infusion pump45300%
Tandem Mobi Mobile AppAlternate controller enabled insulin infusion pump4433400%
T Slim X2 Basal-Iq Mg/DlAutomated insulin dosing , threshold suspend43500%
T Slim X2 With Basal-Iq TechnologyAlternate controller enabled insulin infusion pump41400%
T Slim X2 Insulin Pump With Control-Iq Technology With T Connect Mobile AppAlternate controller enabled insulin infusion pump29600%
Tandem T Slim Insulin Delivery SysPump, infusion, insulin28600%
Tandem T Slim Insulin Deliver SystemPump, infusion, insulin27300%
T Slim X2 Insulin Pump With Interoperable Technology With T Connect MobiAlternate controller enabled insulin infusion pump18400%
Dexcom G6 Continuous Glucose Monitoring SystemIntegrated continuous glucose monitoring system, factory calibrated4361,7100%
Autosoft XcSet, administration, intravascular1490%
CartridgeSet, tubing, blood, with and without anti-regurgitation valve103%
Infusion PumpPump, infusion, implanted, programmable163.7%

Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Device types

Product codeDevice typeReportsShare
QFGAlternate controller enabled insulin infusion pump1,042,45575.9%
OZOAutomated insulin dosing , threshold suspend143,70710.5%
LZGPump, infusion, insulin103,2317.5%
OYCPump, infusion, insulin, to be used with invasive glucose sensor84,3206.1%
QBJIntegrated continuous glucose monitoring system, factory calibrated750%
PQFSensor, glucose, invasive, non-adjunctive200%
QJIInteroperable automated glycemic controller70%
FPASet, administration, intravascular50%
FRNPump, infusion50%
OUGMedical device data system30%

Reports by month, five years

013,80627,612Sep 2021: 8,327Oct 2021: 8,467Nov 2021: 10,950Dec 2021: 11,2382022Jan 2022: 8,935Feb 2022: 10,155Mar 2022: 11,087Apr 2022: 11,806May 2022: 11,114Jun 2022: 13,004Jul 2022: 12,185Aug 2022: 14,235Sep 2022: 11,809Oct 2022: 12,935Nov 2022: 13,619Dec 2022: 14,9702023Jan 2023: 13,004Feb 2023: 13,742Mar 2023: 16,567Apr 2023: 14,184May 2023: 15,628Jun 2023: 15,803Jul 2023: 14,362Aug 2023: 17,266Sep 2023: 14,289Oct 2023: 15,838Nov 2023: 15,942Dec 2023: 15,4212024Jan 2024: 16,332Feb 2024: 14,615Mar 2024: 19,290Apr 2024: 20,131May 2024: 19,839Jun 2024: 16,843Jul 2024: 25,568Aug 2024: 25,141Sep 2024: 20,209Oct 2024: 22,016Nov 2024: 16,777Dec 2024: 20,7552025Jan 2025: 24,414Feb 2025: 16,530Mar 2025: 18,863Apr 2025: 20,250May 2025: 19,801Jun 2025: 17,005Jul 2025: 27,612Aug 2025: 22,750Sep 2025: 22,085Oct 2025: 22,270Nov 2025: 18,541Dec 2025: 23,4382026Jan 2026: 19,747Feb 2026: 18,914Mar 2026: 20,755Apr 2026: 19,731May 2026: 18,661Jun 2026: 20,033Jul 2026: 20,856Aug 2026: 19,615

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type

Death0%312
Injury11.9%164,012
Malfunction88%1,208,913
Other0%6
Not given0%7

Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.

Questions about Tandem Diabetes Care reports

How many FDA device reports name Tandem Diabetes Care as manufacturer?

1,373,250 reports through August 2026, 244,646 of them in the latest 12 months.

Which of its brands appear most often?

t:slim X2 Insulin Pump with Control-IQ Technology (584,122), t:slim X2 Insulin Pump with Interoperable Technology (with t:connect mobile app) (267,629), t:slim X2 Insulin Pump with Basal-IQ Technology (142,635), t:slim X2 Insulin Pump with Control-IQ+ Technology (65,297) and Tandem T Slim Insulin Delivery System (52,251).

Which device types does it report on?

alternate controller enabled insulin infusion pump (75.9%), automated insulin dosing , threshold suspend (10.5%), pump, infusion, insulin (7.5%) and pump, infusion, insulin, to be used with invasive glucose sensor (6.1%).

Does a high count say something about the manufacturer?

Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.